Stay updated on Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial

Sign up to get notified when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Screenshots show no visible additions or deletions; page content appears unchanged between versions.
    Difference
    0.1%
    Check dated 2026-04-02T04:52:34.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new site revision v3.5.0 has been added and the older revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:25:54.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    - Page template revision updated from v3.4.2 to v3.4.3. This is a metadata/update that does not affect study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-03-11T18:12:46.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the prior government funding status notice associated with v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T06:32:02.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    A new system notice about government funding has been added. The site revision updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T05:23:14.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels to show 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a new footer 'Revision: v3.4.0', while the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and version 'Revision: v3.3.4' were replaced.
    Difference
    0.2%
    Check dated 2026-01-28T02:58:46.000Z thumbnail image

Stay in the know with updates to Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.